Medical Condition News

RSS

Reactivation of divergent signaling pathways can be leveraged to enhance cancer treatment

In order for cancer to form in the human body, normal cells must acquire multiple mutations before they develop toward the disease.

23 Jul 2020

Amyloid plaques may act as trigger for Alzheimer's disease

The brains of people living with Alzheimer's are riddled with plaques: protein aggregates consisting mainly of amyloid-beta.

23 Jul 2020

Ashion Analytics and Elevation Oncology form innovative cancer treatment partnership

Ashion Analytics LLC today announced a partnership with Elevation Oncology, a clinical stage biopharmaceutical company, focused on the matching of patients with tumors harboring an NRG1 gene fusion identified using Ashion's proprietary GEM ExTra test with CRESTONE, a registration-directed Phase 2 study sponsored by Elevation Oncology.

23 Jul 2020

Study finds viable drug target for triple negative breast cancer

One member of a larger family of oxygen sensing enzymes could offer a viable target for triple negative breast cancer (TNBC), UTSW researchers report in a new study.

23 Jul 2020

The American Society of Nephrology and HHS announce winners of kidneyx redesign dialysis competition

Today, the U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) announced the six winners of the $3 million KidneyX: Redesign Dialysis Phase 2 competition during the virtual KidneyX Summit.

23 Jul 2020

New approach tracks tumors in real time, could improve outcomes for cancer patients

A team of University of Alberta researchers has developed a faster way of tracking the movement of tumours in the body during radiation therapy, which could significantly improve outcomes for cancer patients.

23 Jul 2020

New method can detect cancer cells in the abdominal cavity in real time

A research team from Tel Aviv University's Zimin Institute for Engineering Solutions Advancing Better Lives, led by Prof. Noam Shomron and doctoral student Artem Danilevsky, has developed a method to detect cancer cells in the abdominal cavity in real time.

22 Jul 2020

Experts use genomic analysis tools to create personalized treatment for kidney cancer patients

Experts at City of Hope and the Translational Genomics Research Institute are using one of the world's most comprehensive genomic analysis tools to map out personalized treatment plans for metastatic kidney cancer patients.

22 Jul 2020

Texas A&M researcher awarded $5 million CPRIT grant to further cancer studies

On May 20, Dr. Tanmay Lele, professor in the Department of Biomedical Engineering at Texas A&M University, received a $5 million Recruitment of Established Investigators grant from the Cancer Prevention and Research Institute of Texas to further knowledge about cancer and how it progresses.

22 Jul 2020

Chocolate consumption linked to reduced risk of heart disease

Eating chocolate at least once a week is linked with a reduced risk of heart disease, according to research published today in the European Journal of Preventive Cardiology, a journal of the European Society of Cardiology.

22 Jul 2020

UVA scientists harness the potential of quantum computers to study genetic diseases

University of Virginia School of Medicine scientists are harnessing the mind-bending potential of quantum computers to help us understand genetic diseases - even before quantum computers are a thing.

22 Jul 2020

Immunotherapeutic intervention to reduce stress prevents tumor metastases

Tel Aviv University researchers have found that the short time period around tumor removal surgery (the weeks before and after surgery) is critical for the prevention of metastases development, which develop when the body is under stress.

22 Jul 2020

Fluoxetine does not improve brain recovery after acute stroke

The antidepressant fluoxetine has been suggested as a means to improve brain recovery after acute stroke.

22 Jul 2020

Study suggests new ways to fight aggressive brain cancer

A mouse model of glioblastoma, an aggressive type of cancer that can occur in the brain, suggests that this recalcitrant cancer originates from a pool of stem cells that can be a significant distance away from the resulting tumors.

22 Jul 2020

Patients diagnosed with cancer are more likely to have severe COVID-19 infection

Cancer patients diagnosed more than 24 months ago are more likely to have a severe COVID-19 infection, research has found. Cancer patients of Asian ethnicity or who were receiving palliative treatment for cancer were also at a higher risk of death from COVID-19.

22 Jul 2020

Research could pave way for using machine learning to guide treatment for Parkinson’s

Skoltech scientists have shown that a pair of artificial neural networks is able to learn to successfully suppress self-sustained collective signaling patterns that are typical of degenerative neurons in the brain.

22 Jul 2020

Psychogenic non-epileptic seizures are often misdiagnosed as epilepsy and increase risk of death

One in four people who are tested for epilepsy do not have the disease but instead have a psychological condition called psychogenic non-epileptic seizures.

22 Jul 2020

Monash University researchers pave way for affordable immunotherapies

Researchers from Monash University’s Institute of Pharmaceutical Sciences are paving the way for accessible and affordable cancer treatment by using powerful nanoscale tools to overcome the high costs and long lead-times associated with one of the world’s newest forms of immunotherapy: CAR-T cell therapy.

22 Jul 2020

Scientists identify cellular mechanism that shows promise in treating cancer

Fighting cancer often means employing a suite of techniques to target the tumor and prevent it from growing and spreading to other parts of the body.

22 Jul 2020

Scientific evidence shows GLDH is a safe biomarker for drug-induced liver injury

Critical Path Institute (C-Path) announced today that the Biomarker Qualification Program (BQP) at the Center for Drug Evaluation and Research (CDER) from the U.S. Food and Drug Administration (FDA) issued a positive response to the Qualification Plan (QP) for glutamate dehydrogenase (GLDH) as a safety biomarker for drug-induced liver injury (DILI), developed by C-Path's Predictive Safety Testing Consortium (PSTC) and Duchenne Regulatory Science Consortium (D-RSC).

22 Jul 2020

Medical Condition News

Reactivation of divergent signaling pathways can be leveraged to enhance cancer treatment

Amyloid plaques may act as trigger for Alzheimer's disease

Ashion Analytics and Elevation Oncology form innovative cancer treatment partnership

Study finds viable drug target for triple negative breast cancer

The American Society of Nephrology and HHS announce winners of kidneyx redesign dialysis competition

New approach tracks tumors in real time, could improve outcomes for cancer patients

New method can detect cancer cells in the abdominal cavity in real time

Experts use genomic analysis tools to create personalized treatment for kidney cancer patients

Texas A&M researcher awarded $5 million CPRIT grant to further cancer studies

Chocolate consumption linked to reduced risk of heart disease

UVA scientists harness the potential of quantum computers to study genetic diseases

Immunotherapeutic intervention to reduce stress prevents tumor metastases

Fluoxetine does not improve brain recovery after acute stroke

Study suggests new ways to fight aggressive brain cancer

Patients diagnosed with cancer are more likely to have severe COVID-19 infection

Research could pave way for using machine learning to guide treatment for Parkinson’s

Psychogenic non-epileptic seizures are often misdiagnosed as epilepsy and increase risk of death

Monash University researchers pave way for affordable immunotherapies

Scientists identify cellular mechanism that shows promise in treating cancer

Scientific evidence shows GLDH is a safe biomarker for drug-induced liver injury

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News